Study questions the benefit of the treatment. Aggressive Alzheimer patient -- a (not a) case for atypical neuroleptics?
Kurz, A.
MMW Fortschritte der Medizin 148(47): 16
2006
ISSN/ISBN: 1438-3276 PMID: 17168181 Document Number: 598620
Document emailed within 1 workday
Related Documents
Masi, G. 1997: Atypical neuroleptics in the treatment of early onset schizophrenia Panminerva Medica 39(3): 215-221Herman, Z.S.; Huzarska, M. 1993: Chronic treatment with atypical neuroleptics sulpiride and metoclopramide increases striatal enkephalins in rat brain Polish Journal of Pharmacology 45(5-6): 493-502
Debroy Kidambi, A.; Tiffin, N.J.; Ramsay, H.M. 2016: Atypical rosacea in a male patient: case study Dermatology Online Journal 22(2)
Hydzik, P.; Balicka-Slusarczyk, B.; Jastrzebski, M. 2011: Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report Przeglad Lekarski 68(8): 499-502
Holt, J.; Stiltner, L.; Wallace, R.; Raetz, J. 2009: Clinical inquiries. do patients at high risk of Alzheimer's disease benefit from early treatment? Journal of Family Practice 58(6): 320-322
Balázs, M.; Kovách, G. 1981: Chronic aggressive hepatitis after methyldopa treatment. Case report with electron-microscopic study Hepato-Gastroenterology 28(4): 199-202
Hertrich, O. 1983: Ataractic treatment in psychiatry and general medicine. Neuroleptics and thymoleptics. 3.1 Neuroleptics Fortschritte der Medizin 101(40): 1823; 1826-1827
Dencker, S.J. 1984: The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective Journal of Clinical Psychiatry 45(5 Part 2): 22-27
Koliaskina, G.I.; Sekirina, T.P.; Androsova, L.V.; Kushner, S.G.; Vasil'eva, E.F.; Burbaeva, O.A.; Morozova, M.A. 2007: The influence of atypical neuroleptics on the immune system of patients with schizophrenia Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 3: 14-19
Jarema, M.; Konieczyńska, Z. 2000: Quality of life in schizophrenic patients treated with classic and "old" atypical neuroleptics Psychiatria Polska 34(2): 275-288
Chitaia, N.N.; Danilov, D.S.; Tiuvina, N.A. 2009: Peculiarities of neuroleptic syndrome in women treated with typical and atypical neuroleptics Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(3): 37-43
Mohundro, B.L.; Pope, K.; Shaw, V.; Hitchcock, K. 2010: Clinical inquiries. which drugs are best when aggressive Alzheimer's patients need medication? Journal of Family Practice 59(10): 595-604
Razak, M.A.; Fazir, M. 2000: Neurological recovery in a patient with recurrent aggressive giant cell tumour of the axis--a case report Medical Journal of Malaysia 55 Suppl C: 97-100
Thavichachart, N.; Worakul, P.; Farlow, M.R. 2011: RAPID progression: tool for screening aggressive course of disease (ACD) in Alzheimer dementia Journal of the Medical Association of Thailand 94(4): 485-489
Toivonen, L.; Heikkilä, J. 1987: Drug treatment of arrhythmias -- cosmetics of the ECG or benefit to the patient Annals of Clinical Research 19(1): 1-4
Pieterse, A.H.; Stalmeier, P.F.; Kroep, J.R.; Stiggelbout, A.M. 2011: Adjuvant cancer treatment: what benefit does the patient consider worthwhile? Nederlands Tijdschrift Voor Geneeskunde 155(45): A3905
Viola, T.A. 2014: Considerations for the treatment of the dental patient with Alzheimer's disease General Dentistry 62(4): 16-19
Smirniotis, V.; Kondi-Pafiti, A.; Theodoraki, K.; Kostopanagiotou, G.; Liapis, A.; Kourias, E. 1997: Aggressive angiomyxoma of the pelvis: a clinicopathologic study of a case Clinical and Experimental Obstetrics and Gynecology 24(4): 209-211
Bhidayasiri, R. 2007: Atypical dementia: when it is not Alzheimer's disease Journal of the Medical Association of Thailand 90(10): 2222-2232
Bouchard, R.H. 2002: Longitudinal comparative study of risperidone vs classical neuroleptics in the treatment of schizophrenia: 24 months of observation L'Encephale 28 Spec no 2 Pt 2: S31-S32